Table of Contents Author Guidelines Submit a Manuscript
Analytical Cellular Pathology
Volume 2017 (2017), Article ID 9404057, 20 pages
https://doi.org/10.1155/2017/9404057
Review Article

Cell Therapies in Cardiomyopathy: Current Status of Clinical Trials

Ming Hao,1,2 Richard Wang,1,2 and Wen Wang1,2

1Cellular Biomedicine Group, 333 Guiping Road, Shanghai 200233, China
2Cellular Biomedicine Group, 19925 Stevens Creek Blvd, Suite 100, Cupertino, CA 95014, USA

Correspondence should be addressed to Wen Wang; moc.puorgdemoibllec@gnaw.llewxam

Received 22 September 2016; Revised 6 December 2016; Accepted 8 December 2016; Published 17 January 2017

Academic Editor: Alain Chapel

Copyright © 2017 Ming Hao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. E. Moran, K. Y. Tzong, M. H. Forouzanfar et al., “Variations in ischemic heart disease burden by age, country, and income: the global burden of diseases, injuries, and risk factors 2010 study,” Global Heart, vol. 9, no. 1, pp. 91–99, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. C. E. Murry, H. Reinecke, and L. M. Pabon, “Regeneration gaps : observations on stem cells and cardiac repair,” Journal of the American College of Cardiology, vol. 47, no. 9, pp. 1777–1785, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Stehlik, L. B. Edwards, A. Y. Kucheryavaya et al., “The registry of the international society for heart and lung transplantation: twenty-eighth adult heart transplant report—2011,” The Journal of Heart and Lung Transplantation, vol. 30, no. 10, pp. 1078–1094, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. J. P. Hellermann, S. J. Jacobsen, B. J. Gersh, R. J. Rodeheffer, G. S. Reeder, and V. L. Roger, “Heart failure after myocardial infarction: a review,” American Journal of Medicine, vol. 113, no. 4, pp. 324–330, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. A. P. Beltrami, K. Urbanek, J. Kajstura et al., “Evidence that human cardiac myocytes divide after myocardial infarction,” The New England Journal of Medicine, vol. 344, no. 23, pp. 1750–1757, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. F. Quaini, K. Urbanek, A. P. Beltrami et al., “Chimerism of the transplanted heart,” The New England Journal of Medicine, vol. 346, no. 1, pp. 5–15, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Kajstura, A. Leri, N. Finato, C. Di Loreto, C. A. Beltrami, and P. Anversa, “Myocyte proliferation in end-stage cardiac failure in humans,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 15, pp. 8801–8805, 1998. View at Publisher · View at Google Scholar · View at Scopus
  8. O. Bergmann, R. D. Bhardwaj, S. Bernard et al., “Evidence for cardiomyocyte renewal in humans,” Science, vol. 324, no. 5923, pp. 98–102, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. P. C. H. Hsieh, V. F. M. Segers, M. E. Davis et al., “Evidence from a genetic fate-mapping study that stem cells refresh adult mammalian cardiomyocytes after injury,” Nature Medicine, vol. 13, no. 8, pp. 970–974, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Abbate, G. G. L. Biondi-Zoccai, D. L. Appleton et al., “Survival and cardiac remodeling benefits in patients undergoing late percutaneous coronary intervention of the infarct-related artery: evidence from a meta-analysis of randomized controlled trials,” Journal of the American College of Cardiology, vol. 51, no. 9, pp. 956–964, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Gyöngyösi, W. Wojakowski, E. P. Navarese, and L. À. Moye, “Meta-analyses of human cell-based cardiac regeneration therapies: controversies in meta-analyses results on cardiac cell-based regenerative studies,” Circulation Research, vol. 118, no. 8, pp. 1254–1263, 2016. View at Publisher · View at Google Scholar · View at Scopus
  12. A. R. Khan, T. A. Farid, A. Pathan et al., “Impact of cell therapy on myocardial perfusion and cardiovascular outcomes in patients with angina refractory to medical therapy: a systematic review and meta-analysis,” Circulation Research, vol. 118, no. 6, pp. 984–993, 2016. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Dominici, K. Le Blanc, I. Mueller et al., “Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement,” Cytotherapy, vol. 8, no. 4, pp. 315–317, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. H. Oh, H. Ito, and S. Sano, “Challenges to success in heart failure: cardiac cell therapies in patients with heart diseases,” Journal of Cardiology, vol. 68, no. 5, pp. 361–367, 2016. View at Publisher · View at Google Scholar
  15. R. Sanz-Ruiz, E. Gutiérrez Ibañes, A. V. Arranz, M. E. Fernández Santos, P. L. S. Fernández, and F. Fernández-Avilés, “Phases I-III clinical trials using adult stem cells,” Stem Cells International, vol. 2010, Article ID 579142, 12 pages, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. J. M. F. Wu, Y.-C. Hsueh, H.-J. Ch'ang et al., “Circulating cells contribute to cardiomyocyte regeneration after injury,” Circulation Research, vol. 116, no. 4, pp. 633–641, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. J. O. Beitnes, O. Gjesdal, K. Lunde et al., “Left ventricular systolic and diastolic function improve after acute myocardial infarction treated with acute percutaneous coronary intervention, but are not influenced by intracoronary injection of autologous mononuclear bone marrow cells: a 3 year serial echocardiographic sub-study of the randomized-controlled ASTAMI study,” European Journal of Echocardiography, vol. 12, no. 2, pp. 98–106, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. C. P. Hodgkinson, A. Bareja, J. A. Gomez, and V. J. Dzau, “Emerging concepts in paracrine mechanisms in regenerative cardiovascular medicine and biology,” Circulation Research, vol. 118, no. 1, pp. 95–107, 2016. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Korf-Klingebiel, T. Kempf, T. Sauer et al., “Bone marrow cells are a rich source of growth factors and cytokines: implications for cell therapy trials after myocardial infarction,” European Heart Journal, vol. 29, no. 23, pp. 2851–2858, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. Y. Yao, J. Huang, Y. Geng et al., “Paracrine action of mesenchymal stem cells revealed by single cell gene profiling in infarcted murine hearts,” PLoS ONE, vol. 10, no. 6, Article ID e0129164, 2015. View at Publisher · View at Google Scholar · View at Scopus
  21. K. S. Rao, A. Aronshtam, K. L. McElory-Yaggy et al., “Human epicardial cell-conditioned medium contains HGF/IgG complexes that phosphorylate RYK and protect against vascular injury,” Cardiovascular Research, vol. 107, no. 2, pp. 277–286, 2015. View at Publisher · View at Google Scholar · View at Scopus
  22. K. Cheng, K. Malliaras, R. R. Smith et al., “Human cardiosphere-derived cells from advanced heart failure patients exhibit augmented functional potency in myocardial repair,” JACC: Heart Failure, vol. 2, no. 1, pp. 49–61, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Miyamoto, N. Kawaguchi, G. M. Ellison, R. Matsuoka, T. Shin'Oka, and H. Kurosawa, “Characterization of long-term cultured c-kit+ cardiac stem cells derived from adult rat hearts,” Stem Cells and Development, vol. 19, no. 1, pp. 105–116, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. N. Kawaguchi, A. J. Smith, C. D. Waring et al., “c-Kitpos GATA-4 high rat cardiac stem cells foster adult cardiomyocyte survival through IGF-1 paracrine signalling,” PLoS ONE, vol. 5, no. 12, Article ID e14297, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Lichtenauer, M. Mildner, A. Baumgartner et al., “Intravenous and intramyocardial injection of apoptotic white blood cell suspensions prevents ventricular remodelling by increasing elastin expression in cardiac scar tissue after myocardial infarction,” Basic Research in Cardiology, vol. 106, no. 4, pp. 645–655, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. L. Barile, V. Lionetti, E. Cervio et al., “Extracellular vesicles from human cardiac progenitor cells inhibit cardiomyocyte apoptosis and improve cardiac function after myocardial infarction,” Cardiovascular Research, vol. 103, no. 4, pp. 530–541, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. A. G.-E. Ibrahim, K. Cheng, and E. Marbán, “Exosomes as critical agents of cardiac regeneration triggered by cell therapy,” Stem Cell Reports, vol. 2, no. 5, pp. 606–619, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. E. Tseliou, G. De Couto, J. Terrovitis et al., “Angiogenesis, cardiomyocyte proliferation and anti-fibrotic effects underlie structural preservation post-infarction by intramyocardially-injected cardiospheres,” PLoS ONE, vol. 9, no. 2, Article ID e88590, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Buckingham and D. Montarras, “Skeletal muscle stem cells,” Current Opinion in Genetics & Development, vol. 18, no. 4, pp. 330–336, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. J. C. Chachques, C. Acar, J. Herreros et al., “Cellular cardiomyoplasty: clinical application,” The Annals of Thoracic Surgery, vol. 77, no. 3, pp. 1121–1130, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. P. Menasché, A. A. Hagège, M. Scorsin et al., “Myoblast transplantation for heart failure,” The Lancet, vol. 357, no. 9252, pp. 279–280, 2001. View at Publisher · View at Google Scholar · View at Scopus
  32. P. Farahmand, T. Y. Y. Lai, R. D. Weisel et al., “Skeletal myoblasts preserve remote matrix architecture and global function when implanted early or late after coronary ligation into infarcted or remote myocardium,” Circulation, vol. 118, no. 14, pp. S130–S137, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. J. Pouly, A. A. Hagège, J.-T. Vilquin et al., “Does the functional efficacy of skeletal myoblast transplantation extend to nonischemic cardiomyopathy?” Circulation, vol. 110, no. 12, pp. 1626–1631, 2004. View at Publisher · View at Google Scholar · View at Scopus
  34. K.-L. He, G.-H. Yi, W. Sherman et al., “Autologous skeletal myoblast transplantation improved hemodynamics and left ventricular function in chronic heart failure dogs,” The Journal of Heart and Lung Transplantation, vol. 24, no. 11, pp. 1940–1949, 2005. View at Publisher · View at Google Scholar · View at Scopus
  35. A. Asakura, M. Komaki, and M. A. Rudnicki, “Muscle satellite cells are multipotential stem cells that exhibit myogenic, osteogenic, and adipogenic differentiation,” Differentiation, vol. 68, no. 4-5, pp. 245–253, 2001. View at Publisher · View at Google Scholar · View at Scopus
  36. Y. Iijima, T. Nagai, M. Mizukami et al., “Beating is necessary for transdifferentiation of skeletal muscle-derived cells into cardiomyocytes,” The FASEB Journal, vol. 17, no. 10, pp. 1361–1363, 2003. View at Google Scholar · View at Scopus
  37. L. Formigli, F. Francini, A. Tani et al., “Morphofunctional integration between skeletal myoblasts and adult cardiomyocytes in coculture is favored by direct cell-cell contacts and relaxin treatment,” American Journal of Physiology—Cell Physiology, vol. 288, no. 4, pp. C795–C804, 2005. View at Publisher · View at Google Scholar · View at Scopus
  38. H. Reinecke, G. H. MacDonald, S. D. Hauschka, and C. E. Murry, “Electromechanical coupling between skeletal and cardiac muscle. Implications for infarct repair,” The Journal of Cell Biology, vol. 149, no. 3, pp. 731–740, 2000. View at Publisher · View at Google Scholar · View at Scopus
  39. P. Menasché, A. A. Hagège, J.-T. Vilquin et al., “Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction,” Journal of the American College of Cardiology, vol. 41, no. 7, pp. 1078–1083, 2003. View at Publisher · View at Google Scholar · View at Scopus
  40. P. Menasché, O. Alfieri, S. Janssens et al., “The myoblast autologous grafting in ischemic cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation,” Circulation, vol. 117, no. 9, pp. 1189–1200, 2008. View at Publisher · View at Google Scholar · View at Scopus
  41. H. Reinecke, V. Poppa, and C. E. Murry, “Skeletal muscle stem cells do not transdifferentiate into cardiomyocytes after cardiac grafting,” Journal of Molecular and Cellular Cardiology, vol. 34, no. 2, pp. 241–249, 2002. View at Publisher · View at Google Scholar · View at Scopus
  42. P. Müller, P. Pfeiffer, J. Koglin et al., “Cardiomyocytes of noncardiac origin in myocardial biopsies of human transplanted hearts,” Circulation, vol. 106, no. 1, pp. 31–35, 2002. View at Publisher · View at Google Scholar · View at Scopus
  43. D. Orlic, J. Kajstura, S. Chimenti et al., “Mobilized bone marrow cells repair the infarcted heart, improving function and survival,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 18, pp. 10344–10349, 2001. View at Publisher · View at Google Scholar · View at Scopus
  44. M. A. Sussman and C. E. Murry, “Bones of contention: marrow-derived cells in myocardial regeneration,” Journal of Molecular and Cellular Cardiology, vol. 44, no. 6, pp. 950–953, 2008. View at Publisher · View at Google Scholar · View at Scopus
  45. L. B. Balsam, A. J. Wagers, J. L. Christensen, T. Kofidis, I. L. Weissmann, and R. C. Robbins, “Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium,” Nature, vol. 428, no. 6983, pp. 668–673, 2004. View at Publisher · View at Google Scholar · View at Scopus
  46. M. Yousef, C. M. Schannwell, M. Köstering, T. Zeus, M. Brehm, and B. E. Strauer, “The BALANCE Study: clinical benefit and long-term outcome after intracoronary autologous bone marrow cell transplantation in patients with acute myocardial infarction,” Journal of the American College of Cardiology, vol. 53, no. 24, pp. 2262–2269, 2009. View at Publisher · View at Google Scholar · View at Scopus
  47. M. F. Pittenger and B. J. Martin, “Mesenchymal stem cells and their potential as cardiac therapeutics,” Circulation Research, vol. 95, no. 1, pp. 9–20, 2004. View at Publisher · View at Google Scholar · View at Scopus
  48. A. Armiñán, C. Gandía, J. M. García-Verdugo et al., “Mesenchymal stem cells provide better results than hematopoietic precursors for the treatment of myocardial infarction,” Journal of the American College of Cardiology, vol. 55, no. 20, pp. 2244–2253, 2010. View at Publisher · View at Google Scholar · View at Scopus
  49. C. Toma, M. F. Pittenger, K. S. Cahill, B. J. Byrne, and P. D. Kessler, “Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart,” Circulation, vol. 105, no. 1, pp. 93–98, 2002. View at Publisher · View at Google Scholar · View at Scopus
  50. T. Asahara, H. Masuda, T. Takahashi et al., “Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization,” Circulation Research, vol. 85, no. 3, pp. 221–228, 1999. View at Publisher · View at Google Scholar
  51. J. M. Hill, G. Zalos, J. P. J. Halcox et al., “Circulating endothelial progenitor cells, vascular function, and cardiovascular risk,” The New England Journal of Medicine, vol. 348, no. 7, pp. 593–600, 2003. View at Publisher · View at Google Scholar · View at Scopus
  52. S. Dimmeler and A. M. Zeiher, “Cell therapy of acute myocardial infarction: open questions,” Cardiology, vol. 113, no. 3, pp. 155–160, 2009. View at Publisher · View at Google Scholar · View at Scopus
  53. J. R. Crosby, W. E. Kaminski, G. Schatteman et al., “Endothelial cells of hematopoietic origin make a significant contribution to adult blood vessel formation,” Circulation Research, vol. 87, no. 9, pp. 728–730, 2000. View at Publisher · View at Google Scholar · View at Scopus
  54. K. Malliaras and E. Marbán, “Cardiac cell therapy: where we've been, where we are, and where we should be headed,” British Medical Bulletin, vol. 98, no. 1, pp. 161–185, 2011. View at Publisher · View at Google Scholar · View at Scopus
  55. D. Orlic, J. Kajstura, S. Chimenti et al., “Bone marrow cells regenerate infarcted myocardium,” Nature, vol. 410, no. 6829, pp. 701–705, 2001. View at Publisher · View at Google Scholar · View at Scopus
  56. B. E. Strauer, M. Brehm, T. Zeus et al., “Intracoronary, human autologous stem cell transplantation for myocardial regeneration following myocardial infarction,” Deutsche Medizinische Wochenschrift, vol. 126, no. 34-35, pp. 932–938, 2001. View at Google Scholar
  57. H.-F. Tse, Y.-L. Kwong, J. K. F. Chan, G. Lo, C.-L. Ho, and C.-P. Lau, “Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation,” The Lancet, vol. 361, no. 9351, pp. 47–49, 2003. View at Publisher · View at Google Scholar · View at Scopus
  58. E. C. Perin, H. F. R. Dohmann, R. Borojevic et al., “Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure,” Circulation, vol. 107, no. 18, pp. 2294–2302, 2003. View at Publisher · View at Google Scholar · View at Scopus
  59. B. Assmus, V. Schächinger, C. Teupe et al., “Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI),” Circulation, vol. 106, no. 24, pp. 3009–3017, 2002. View at Publisher · View at Google Scholar · View at Scopus
  60. D. M. Leistner, U. Fischer-Rasokat, J. Honold et al., “Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI): final 5-year results suggest long-term safety and efficacy,” Clinical Research in Cardiology, vol. 100, no. 10, pp. 925–934, 2011. View at Publisher · View at Google Scholar · View at Scopus
  61. G. P. Meyer, K. C. Wollert, J. Lotz et al., “Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial,” Circulation, vol. 113, no. 10, pp. 1287–1294, 2006. View at Publisher · View at Google Scholar · View at Scopus
  62. K. Lunde, S. Solheim, S. Aakhus et al., “Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction,” The New England Journal of Medicine, vol. 355, no. 12, pp. 1199–1209, 2006. View at Publisher · View at Google Scholar · View at Scopus
  63. S. Janssens, C. Dubois, J. Bogaert et al., “Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial,” The Lancet, vol. 367, no. 9505, pp. 113–121, 2006. View at Publisher · View at Google Scholar · View at Scopus
  64. J. O. Beitnes, E. Hopp, K. Lunde et al., “Long-term results after intracoronary injection of autologous mononuclear bone marrow cells in acute myocardial infarction: the ASTAMI randomised, controlled study,” Heart, vol. 95, no. 24, pp. 1983–1989, 2009. View at Publisher · View at Google Scholar · View at Scopus
  65. J. H. Traverse, T. D. Henry, C. J. Pepine et al., “Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trial,” JAMA, vol. 308, no. 22, pp. 2380–2389, 2012. View at Google Scholar
  66. M. Gyöngyösi, I. Lang, M. Dettke et al., “Combined delivery approach of bone marrow mononuclear stem cells early and late after myocardial infarction: the MYSTAR prospective, randomized study,” Nature Clinical Practice Cardiovascular Medicine, vol. 6, no. 1, pp. 70–81, 2009. View at Publisher · View at Google Scholar · View at Scopus
  67. M. Tendera, W. Wojakowski, W. Ruyłło et al., “Intracoronary infusion of bone marrow-derived selected CD34 +CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration by Intracoronary Infusion of Selected Population of Stem Cells in Acute Myocardial Infarction (REGENT) Trial,” European Heart Journal, vol. 30, no. 11, pp. 1313–1321, 2009. View at Publisher · View at Google Scholar · View at Scopus
  68. B.-E. Strauer, M. Yousef, and C. M. Schannwell, “The acute and long-term effects of intracoronary Stem cell Transplantation in 191 patients with chronic heARt failure: the STAR-heart study,” European Journal of Heart Failure, vol. 12, no. 7, pp. 721–729, 2010. View at Publisher · View at Google Scholar · View at Scopus
  69. D. Sürder, R. Manka, V. Lo Cicero et al., “Intracoronary injection of bone marrow-derived mononuclear cells early or late after acute myocardial infarction: effects on global left ventricular function,” Circulation, vol. 127, no. 19, pp. 1968–1979, 2013. View at Publisher · View at Google Scholar · View at Scopus
  70. R. E. Michler, “Stem cell therapy for heart failure,” Cardiology in Review, vol. 22, no. 3, pp. 105–116, 2014. View at Publisher · View at Google Scholar · View at Scopus
  71. V. Jeevanantham, M. Butler, A. Saad, A. Abdel-Latif, E. K. Zuba-Surma, and B. Dawn, “Adult bone marrow cell therapy improves survival and induces long-term improvement in cardiac parameters: a systematic review and meta-analysis,” Circulation, vol. 126, no. 5, pp. 551–568, 2012. View at Publisher · View at Google Scholar · View at Scopus
  72. H. Zimmet, P. Porapakkham, P. Porapakkham et al., “Short-and long-term outcomes of intracoronary and endogenously mobilized bone marrow stem cells in the treatment of ST-segment elevation myocardial infarction: a meta-analysis of randomized control trials,” European Journal of Heart Failure, vol. 14, no. 1, pp. 91–105, 2012. View at Publisher · View at Google Scholar · View at Scopus
  73. C. Griesel, H.-G. Heuft, D. Herrmann et al., “Good manufacturing practice-compliant validation and preparation of BM cells for the therapy of acute myocardial infarction,” Cytotherapy, vol. 9, no. 1, pp. 35–43, 2007. View at Publisher · View at Google Scholar · View at Scopus
  74. S. K. Sanganalmath and R. Bolli, “Cell therapy for heart failure: a comprehensive overview of experimental and clinical studies, current challenges, and future directions,” Circulation Research, vol. 113, no. 6, pp. 810–834, 2013. View at Publisher · View at Google Scholar · View at Scopus
  75. M. F. Pittenger, A. M. Mackay, S. C. Beck et al., “Multilineage potential of adult human mesenchymal stem cells,” Science, vol. 284, no. 5411, pp. 143–147, 1999. View at Publisher · View at Google Scholar
  76. S. Aggarwal and M. F. Pittenger, “Human mesenchymal stem cells modulate allogeneic immune cell responses,” Blood, vol. 105, no. 4, pp. 1815–1822, 2005. View at Publisher · View at Google Scholar · View at Scopus
  77. J.-F. Liu, B.-W. Wang, H.-F. Hung, H. Chang, and K.-G. Shyu, “Human mesenchymal stem cells improve myocardial performance in a splenectomized rat model of chronic myocardial infarction,” Journal of the Formosan Medical Association, vol. 107, no. 2, pp. 165–174, 2008. View at Publisher · View at Google Scholar · View at Scopus
  78. L. Li, S. Zhang, Y. Zhang, B. Yu, Y. Xu, and Z. Guan, “Paracrine action mediate the antifibrotic effect of transplanted mesenchymal stem cells in a rat model of global heart failure,” Molecular Biology Reports, vol. 36, no. 4, pp. 725–731, 2009. View at Publisher · View at Google Scholar · View at Scopus
  79. M. Mazo, J. J. Gavira, G. Abizanda et al., “Transplantation of mesenchymal stem cells exerts a greater long-term effect than bone marrow mononuclear cells in a chronic myocardial infarction model in rat,” Cell Transplantation, vol. 19, no. 3, pp. 313–328, 2010. View at Publisher · View at Google Scholar · View at Scopus
  80. J. M. Hare, J. H. Traverse, T. D. Henry et al., “A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction,” Journal of the American College of Cardiology, vol. 54, no. 24, pp. 2277–2286, 2009. View at Publisher · View at Google Scholar · View at Scopus
  81. V. Karantalis, D. L. Difede, G. Gerstenblith et al., “Autologous mesenchymal stem cells produce concordant improvements in regional function, tissue perfusion, and fibrotic burden when administered to patients undergoing coronary artery bypass grafting: the Prospective Randomized Study of Mesenchymal Stem Cell Therapy in Patients Undergoing Cardiac Surgery (PROMETHEUS) trial,” Circulation Research, vol. 114, no. 8, pp. 1302–1310, 2014. View at Publisher · View at Google Scholar · View at Scopus
  82. J. M. Hare, J. E. Fishman, G. Gerstenblith et al., “Comparison of allogeneic vs autologous bone marrow-derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial,” JAMA, vol. 308, no. 22, pp. 2369–2379, 2012. View at Publisher · View at Google Scholar
  83. The TRansendocardial Stem Cell Injection Delivery Effects on Neomyogenesis STudy (The TRIDENT Study) (Trident) (NCT02013674), https://www.clinicaltrials.gov/.
  84. L. R. Gao, Y. Chen, N. K. Zhang et al., “Intracoronary infusion of Wharton's jelly-derived mesenchymal stem cells in acute myocardial infarction: double-blind, randomized controlled trial,” BMC Medicine, vol. 13, article 162, 2015. View at Publisher · View at Google Scholar · View at Scopus
  85. J.-W. Lee, S.-H. Lee, Y.-J. Youn et al., “A randomized, open-label, multicenter trial for the safety and efficacy of adult mesenchymal stem cells after acute myocardial infarction,” Journal of Korean Medical Science, vol. 29, no. 1, pp. 23–31, 2014. View at Publisher · View at Google Scholar · View at Scopus
  86. “A Study of Allogeneic Mesenchymal Bone Marrow Cells in Subjects With ST Segment Elevation Myocardial Infarction (STEMI) (NCT01770613),” https://clinicaltrials.gov/.
  87. “RELIEF(A Randomized,Open labEled, muLticenter Trial for Safety and Efficacy of Intracoronary Adult Human Mesenchymal stEm Cells Acute Myocardial inFarction) (NCT01652209),” https://clinicaltrials.gov/.
  88. X. Bai, Y. Yan, Y.-H. Song et al., “Both cultured and freshly isolated adipose tissue-derived stem cells enhance cardiac function after acute myocardial infarction,” European Heart Journal, vol. 31, no. 4, pp. 489–501, 2010. View at Publisher · View at Google Scholar · View at Scopus
  89. B. Lindroos, R. Suuronen, and S. Miettinen, “The potential of adipose stem cells in regenerative medicine,” Stem Cell Reviews and Reports, vol. 7, no. 2, pp. 269–291, 2011. View at Publisher · View at Google Scholar · View at Scopus
  90. R. Yañez, M. L. Lamana, J. García-Castro, I. Colmenero, M. Ramírez, and J. A. Bueren, “Adipose tissue-derived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of the graft-versus-host disease,” Stem Cells, vol. 24, no. 11, pp. 2582–2591, 2006. View at Publisher · View at Google Scholar · View at Scopus
  91. V. Planat-Bénard, C. Menard, M. André et al., “Spontaneous cardiomyocyte differentiation from adipose tissue stroma cells,” Circulation Research, vol. 94, no. 2, pp. 223–229, 2004. View at Publisher · View at Google Scholar · View at Scopus
  92. A. Miranville, C. Heeschen, C. Sengenès, C. A. Curat, R. Busse, and A. Bouloumié, “Improvement of postnatal neovascularization by human adipose tissue-derived stem cells,” Circulation, vol. 110, no. 3, pp. 349–355, 2004. View at Publisher · View at Google Scholar · View at Scopus
  93. T. Rada, R. L. Reis, and M. E. Gomes, “Distinct stem cells subpopulations isolated from human adipose tissue exhibit different chondrogenic and osteogenic differentiation potential,” Stem Cell Reviews and Reports, vol. 7, no. 1, pp. 64–76, 2011. View at Publisher · View at Google Scholar · View at Scopus
  94. M. Mazo, V. Planat-Bénard, G. Abizanda et al., “Transplantation of adipose derived stromal cells is associated with functional improvement in a rat model of chronic myocardial infarction,” European Journal of Heart Failure, vol. 10, no. 5, pp. 454–462, 2008. View at Publisher · View at Google Scholar · View at Scopus
  95. L. Wang, J. Deng, W. Tian et al., “Adipose-derived stem cells are an effective cell candidate for treatment of heart failure: an MR imaging study of rat hearts,” American Journal of Physiology - Heart and Circulatory Physiology, vol. 297, no. 3, pp. H1020–H1031, 2009. View at Publisher · View at Google Scholar · View at Scopus
  96. Randomized Clinical Trial of Adipose-Derived Stem Cells in the Treatment of Pts With ST-elevation Myocardial Infarction (NCT00442806), https://www.clinicaltrials.gov/.
  97. “CSCC_ASC Therapy in Patients with Severe Heart Failure (NCT02387723),” https://clinicaltrials.gov/.
  98. E. C. Perin, R. Sanz-Ruiz, P. L. Sánchez et al., “Adipose-derived regenerative cells in patients with ischemic cardiomyopathy: the PRECISE Trial,” American Heart Journal, vol. 168, no. 1, pp. 88.e2–95.e2, 2014. View at Publisher · View at Google Scholar · View at Scopus
  99. T. A. Deisher, “Cardiac-derived stem cells,” IDrugs, vol. 3, no. 6, pp. 649–653, 2000. View at Google Scholar · View at Scopus
  100. I. L. Weissman, D. J. Anderson, and F. Gage, “Stem and progenitor cells: origins, phenotypes, lineage commitments, and transdifferentiations,” Annual Review of Cell and Developmental Biology, vol. 17, pp. 387–403, 2001. View at Publisher · View at Google Scholar · View at Scopus
  101. A. P. Beltrami, L. Barlucchi, D. Torella et al., “Adult cardiac stem cells are multipotent and support myocardial regeneration,” Cell, vol. 114, no. 6, pp. 763–776, 2003. View at Publisher · View at Google Scholar · View at Scopus
  102. H. Oh, S. B. Bradfute, T. D. Gallardo et al., “Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 21, pp. 12313–12318, 2003. View at Publisher · View at Google Scholar · View at Scopus
  103. K. L. Laugwitz, A. Moretti, J. Lam et al., “Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages,” Nature, vol. 433, pp. 647–653, 2005. View at Publisher · View at Google Scholar
  104. H. C. Ott, T. S. Matthiesen, J. Brechtken et al., “The adult human heart as a source for stem cells: repair strategies with embryonic-like progenitor cells,” Nature Clinical Practice Cardiovascular Medicine, vol. 4, supplement 1, pp. S27–S39, 2007. View at Publisher · View at Google Scholar · View at Scopus
  105. M. Noseda, M. Harada, S. McSweeney et al., “PDGFRα demarcates the cardiogenic clonogenic Sca1+ stem/progenitor cell in adult murine myocardium,” Nature Communications, vol. 6, article 6930, 2015. View at Publisher · View at Google Scholar · View at Scopus
  106. C. M. Martin, A. P. Meeson, S. M. Robertson et al., “Persistent expression of the ATP-binding cassette transporter, Abcg2, identifies cardiac SP cells in the developing and adult heart,” Developmental Biology, vol. 265, no. 1, pp. 262–275, 2004. View at Publisher · View at Google Scholar · View at Scopus
  107. E. Messina, L. De Angelis, G. Frati et al., “Isolation and expansion of adult cardiac stem cells from human and murine heart,” Circulation Research, vol. 95, no. 9, pp. 911–921, 2004. View at Publisher · View at Google Scholar · View at Scopus
  108. P. Menasché and V. Vanneaux, “Stem cells for the treatment of heart failure,” Current Research in Translational Medicine, vol. 64, no. 2, pp. 97–106, 2016. View at Publisher · View at Google Scholar
  109. M. T.-L. Discorde, S. Prost, E. Nandrot, and M. Kirszenbaum, “Spatial and temporal mapping of c-kit and its ligand, stem cell factor expression during human embryonic haemopoiesis,” British Journal of Haematology, vol. 107, no. 2, pp. 247–253, 1999. View at Publisher · View at Google Scholar · View at Scopus
  110. T. Kunisada, H. Yoshida, H. Yamazaki et al., “Transgene expression of steel factor in the basal layer of epidermis promotes survival, proliferation, differentiation and migration of melanocyte precursors,” Development, vol. 125, no. 15, pp. 2915–2923, 1998. View at Google Scholar · View at Scopus
  111. B. Nadal-Ginard, J. Kajstura, A. Leri, and P. Anversa, “Myocyte death, growth, and regeneration in cardiac hypertrophy and failure,” Circulation Research, vol. 92, no. 2, pp. 139–150, 2003. View at Publisher · View at Google Scholar · View at Scopus
  112. P. P. Zwetsloot, A. M. D. Végh, S. J. Jansen Of Lorkeers et al., “Cardiac stem cell treatment in myocardial infarction: a systematic review and meta-analysis of preclinical studies,” Circulation Research, vol. 118, no. 8, pp. 1223–1232, 2016. View at Publisher · View at Google Scholar · View at Scopus
  113. X. L. Tang, Q. Li, G. Rokosh et al., “Long-term outcome of administration of c-kit(POS) cardiac progenitor cells after acute myocardial infarction: transplanted cells do not become cardiomyocytes, but structural and functional improvement and proliferation of endogenous cells persist for at least one year,” Circulation Research, vol. 118, pp. 1091–1105, 2016. View at Google Scholar
  114. R. Bolli, A. R. Chugh, D. D'Amario et al., “Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial,” The Lancet, vol. 378, no. 9806, pp. 1847–1857, 2011. View at Publisher · View at Google Scholar · View at Scopus
  115. “Combination of Mesenchymal and C-kit+ Cardiac Stem Cells as Regenerative Therapy for Heart Failure (CONCERT-HF) (NCT02501811),” https://clinicaltrials.gov/.
  116. M. T. Armstrong, D. Y. Lee, and P. B. Armstrong, “Regulation of proliferation of the fetal myocardium,” Developmental Dynamics, vol. 219, no. 2, pp. 226–236, 2000. View at Publisher · View at Google Scholar · View at Scopus
  117. S. K. Nilsson and P. J. Simmons, “Transplantable stem cells: home to specific niches,” Current Opinion in Hematology, vol. 11, no. 2, pp. 102–106, 2004. View at Publisher · View at Google Scholar · View at Scopus
  118. T.-S. Li, K. Cheng, K. Malliaras et al., “Direct comparison of different stem cell types and subpopulations reveals superior paracrine potency and myocardial repair efficacy with cardiosphere-derived cells,” Journal of the American College of Cardiology, vol. 59, no. 10, pp. 942–953, 2012. View at Publisher · View at Google Scholar · View at Scopus
  119. R. R. Makkar, R. R. Smith, K. Cheng et al., “Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial,” The Lancet, vol. 379, no. 9819, pp. 895–904, 2012. View at Publisher · View at Google Scholar · View at Scopus
  120. “AutoLogous Human Cardiac-Derived Stem Cell to Treat Ischemic Cardiomyopathy (ALCADIA) (ALCADIA) (NCT00981006),” https://clinicaltrials.gov/.
  121. K. Malliaras, R. R. Makkar, R. R. Smith et al., “Intracoronary cardiosphere-derived cells after myocardial infarction : evidence of therapeutic regeneration in the final 1-year results of the CADUCEUS trial (CArdiosphere-derived aUtologous stem CElls to reverse ventricUlar dySfunction),” Journal of the American College of Cardiology, vol. 63, no. 2, pp. 110–122, 2014. View at Publisher · View at Google Scholar · View at Scopus
  122. P. V. Johnston, T. Sasano, K. Mills et al., “Engraftment, differentiation, and functional benefits of autologous cardiosphere-derived cells in porcine ischemic cardiomyopathy,” Circulation, vol. 120, no. 12, pp. 1075–1083, 2009. View at Publisher · View at Google Scholar · View at Scopus
  123. K. Tateishi, E. Ashihara, S. Honsho et al., “Human cardiac stem cells exhibit mesenchymal features and are maintained through Akt/GSK-3β signaling,” Biochemical and Biophysical Research Communications, vol. 352, no. 3, pp. 635–641, 2007. View at Publisher · View at Google Scholar · View at Scopus
  124. S. J. Jansen of Lorkeers, J. E. C. Eding, H. M. Vesterinen et al., “Similar effect of autologous and allogeneic cell therapy for ischemic heart disease: systematic review and meta-analysis of large animal studies,” Circulation Research, vol. 116, no. 1, pp. 80–86, 2015. View at Publisher · View at Google Scholar · View at Scopus
  125. “Allogeneic Heart Stem Cells to Achieve Myocardial Regeneration (ALLSTAR) (NCT01458405),” https://clinicaltrials.gov/.
  126. “Dilated cardiomYopathy iNtervention with Allogeneic MyocardIally-regenerative Cells (DYNAMIC) (DYNAMIC) (NCT02293603),” https://clinicaltrials.gov/.
  127. “HOPE-Duchenne (Halt cardiomyOPathy progression in Duchenne) (HOPE) (NCT02485938),” https://clinicaltrials.gov/.
  128. C. E. Murry and G. Keller, “Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development,” Cell, vol. 132, no. 4, pp. 661–680, 2008. View at Publisher · View at Google Scholar · View at Scopus
  129. I. Huber, I. Itzhaki, O. Caspi et al., “Identification and selection of cardiomyocytes during human embryonic stem cell differentiation,” The FASEB Journal, vol. 21, no. 10, pp. 2551–2563, 2007. View at Publisher · View at Google Scholar · View at Scopus
  130. K. R. Boheler, D. G. Crider, Y. Tarasova, and V. A. Maltsev, “Cardiomyocytes derived from embryonic stem cells,” Methods in Molecular Medicine, vol. 108, pp. 417–435, 2005. View at Google Scholar
  131. A. C. Fijnvandraat, A. C. G. Van Ginneken, C. A. Schumacher et al., “Cardiomyocytes purified from differentiated embryonic stem cells exhibit characteristics of early chamber myocardium,” Journal of Molecular and Cellular Cardiology, vol. 35, no. 12, pp. 1461–1472, 2003. View at Publisher · View at Google Scholar · View at Scopus
  132. A. C. Fijnvandraat, R. H. Lekanne Deprez, and A. F. M. Moorman, “Development of heart muscle-cell diversity: a help or a hindrance for phenotyping embryonic stem cell-derived cardiomyocytes,” Cardiovascular Research, vol. 58, no. 2, pp. 303–312, 2003. View at Publisher · View at Google Scholar · View at Scopus
  133. T. J. Nelson, Z.-D. Ge, J. Van Orman et al., “Improved cardiac function in infarcted mice after treatment with pluripotent embryonic stem cells,” The Anatomical Record—Part A Discoveries in Molecular, Cellular, and Evolutionary Biology, vol. 288, no. 11, pp. 1216–1224, 2006. View at Publisher · View at Google Scholar · View at Scopus
  134. H. Qiao, H. Zhang, S. Yamanaka et al., “Long-term improvement in postinfarct left ventricular global and regional contractile function is mediated by embryonic stem cell-derived cardiomyocytes,” Circulation: Cardiovascular Imaging, vol. 4, no. 1, pp. 33–41, 2011. View at Publisher · View at Google Scholar · View at Scopus
  135. R. Passier, L. W. Van Laake, and C. L. Mummery, “Stem-cell-based therapy and lessons from the heart,” Nature, vol. 453, no. 7193, pp. 322–329, 2008. View at Publisher · View at Google Scholar · View at Scopus
  136. J. Nussbaum, E. Minami, M. A. Laflamme et al., “Transplantation of undifferentiated murine embryonic stem cells in the heart: teratoma formation and immune response,” FASEB Journal, vol. 21, no. 7, pp. 1345–1357, 2007. View at Publisher · View at Google Scholar · View at Scopus
  137. Transplantation of Human Embryonic Stem Cell-derived Progenitors in Severe Heart Failure (ESCORT) (NCT02057900), https://www.clinicaltrials.gov/.
  138. K. Takahashi, K. Tanabe, M. Ohnuki et al., “Induction of pluripotent stem cells from adult human fibroblasts by defined factors,” Cell, vol. 131, no. 5, pp. 861–872, 2007. View at Publisher · View at Google Scholar · View at Scopus
  139. G. Narazaki, H. Uosaki, M. Teranishi et al., “Directed and systematic differentiation of cardiovascular cells from mouse induced pluripotent stem cells,” Circulation, vol. 118, no. 5, pp. 498–506, 2008. View at Publisher · View at Google Scholar · View at Scopus
  140. J. Zhang, G. F. Wilson, A. G. Soerens et al., “Functional cardiomyocytes derived from human induced pluripotent stem cells,” Circulation Research, vol. 104, no. 4, pp. e30–e41, 2009. View at Publisher · View at Google Scholar · View at Scopus
  141. L. Yang, M. H. Soonpaa, E. D. Adler et al., “Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population,” Nature, vol. 453, no. 7194, pp. 524–528, 2008. View at Publisher · View at Google Scholar · View at Scopus
  142. X. Q. Xu, R. Graichen, S. Y. Soo et al., “Chemically defined medium supporting cardiomyocyte differentiation of human embryonic stem cells,” Differentiation, vol. 76, no. 9, pp. 958–970, 2008. View at Publisher · View at Google Scholar · View at Scopus
  143. M. A. Laflamme, K. Y. Chen, A. V. Naumova et al., “Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts,” Nature Biotechnology, vol. 25, no. 9, pp. 1015–1024, 2007. View at Publisher · View at Google Scholar · View at Scopus
  144. C. Freund and C. L. Mummery, “Prospects for pluripotent stem cell-derived cardiomyocytes in cardiac cell therapy and as disease models,” Journal of Cellular Biochemistry, vol. 107, no. 4, pp. 592–599, 2009. View at Publisher · View at Google Scholar · View at Scopus
  145. J. A. Efe, S. Hilcove, J. Kim et al., “Conversion of mouse fibroblasts into cardiomyocytes using a direct reprogramming strategy,” Nature Cell Biology, vol. 13, no. 3, pp. 215–222, 2011. View at Publisher · View at Google Scholar · View at Scopus
  146. M. Ieda, J.-D. Fu, P. Delgado-Olguin et al., “Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors,” Cell, vol. 142, no. 3, pp. 375–386, 2010. View at Publisher · View at Google Scholar · View at Scopus
  147. Derivation of Human Induced Pluripotent Stem (iPS) Cells to Heritable Cardiac Arrhythmias (NCT02413450), https://www.clinicaltrials.gov/.
  148. “Blood Collection From Healthy Volunteers and Patients for the Production of Clinical Grade Induced Pluripotent Stem Cell (iPSC) Products (NCT02056613),” https://clinicaltrials.gov/.
  149. M. A. Laflamme and C. E. Murry, “Regenerating the heart,” Nature Biotechnology, vol. 23, no. 7, pp. 845–856, 2005. View at Publisher · View at Google Scholar · View at Scopus
  150. J. Terrovitis, R. Lautamäki, M. Bonios et al., “Noninvasive quantification and optimization of acute cell retention by in vivo positron emission tomography after intramyocardial cardiac-derived stem cell delivery,” Journal of the American College of Cardiology, vol. 54, no. 17, pp. 1619–1626, 2009. View at Publisher · View at Google Scholar · View at Scopus
  151. A. C. P. Diederichsen, J. E. Møller, P. Thayssen et al., “Changes in left ventricular filling patterns after repeated injection of autologous bone marrow cells in heart failure patients,” Scandinavian Cardiovascular Journal, vol. 44, no. 3, pp. 139–145, 2010. View at Publisher · View at Google Scholar · View at Scopus
  152. Q. Yu, Q. Li, R. Na et al., “Impact of repeated intravenous bone marrow mesenchymal stem cells infusion on myocardial collagen network remodeling in a rat model of doxorubicin-induced dilated cardiomyopathy,” Molecular and Cellular Biochemistry, vol. 387, no. 1-2, pp. 279–285, 2014. View at Publisher · View at Google Scholar · View at Scopus
  153. H. Reich, E. Tseliou, G. de Couto et al., “Repeated transplantation of allogeneic cardiosphere-derived cells boosts therapeutic benefits without immune sensitization in a rat model of myocardial infarction,” The Journal of Heart and Lung Transplantation, vol. 35, no. 11, pp. 1348–1357, 2016. View at Publisher · View at Google Scholar
  154. T. Freyman, G. Polin, H. Osman et al., “A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction,” European Heart Journal, vol. 27, no. 9, pp. 1114–1122, 2006. View at Publisher · View at Google Scholar · View at Scopus
  155. Prochymal (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI) (NCT00877903), https://www.clinicaltrials.gov/.
  156. A. N. Patel, L. Geffner, R. F. Vina et al., “Surgical treatment for congestive heart failure with autologous adult stem cell transplantation: a prospective randomized study,” The Journal of Thoracic and Cardiovascular Surgery, vol. 130, no. 6, pp. 1631–1638, 2005. View at Publisher · View at Google Scholar · View at Scopus
  157. T. Siminiak, D. Fiszer, O. Jerzykowska et al., “Percutaneous trans-coronary-venous transplantation of autologous skeletal myoblasts in the treatment of post-infarction myocardial contractility impairment: the POZNAN trial,” European Heart Journal, vol. 26, no. 12, pp. 1188–1195, 2005. View at Publisher · View at Google Scholar · View at Scopus
  158. S. Charwat, I. Lang, M. Dettke et al., “Effect of intramyocardial delivery of autologous bone marrow mononuclear stem cells on the regional myocardial perfusion. NOGA-guided subanalysis of the MYSTAR prospective randomised study,” Thrombosis and Haemostasis, vol. 103, no. 3, pp. 564–571, 2010. View at Publisher · View at Google Scholar · View at Scopus
  159. Q. Li, Y. Guo, Q. Ou et al., “Intracoronary administration of cardiac stem cells in mice: a new, improved technique for cell therapy in murine models,” Basic Research in Cardiology, vol. 106, no. 5, pp. 849–864, 2011. View at Publisher · View at Google Scholar · View at Scopus
  160. J. Tongers, D. W. Losordo, and U. Landmesser, “Stem and progenitor cell-based therapy in ischaemic heart disease: promise, uncertainties, and challenges,” European Heart Journal, vol. 32, no. 10, pp. 1197–1206, 2011. View at Publisher · View at Google Scholar · View at Scopus
  161. M. Hofmann, K. C. Wollert, G. P. Meyer et al., “Monitoring of bone marrow cell homing into the infarcted human myocardium,” Circulation, vol. 111, no. 17, pp. 2198–2202, 2005. View at Publisher · View at Google Scholar · View at Scopus
  162. J. V. Terrovitis, R. R. Smith, and E. Marbán, “Assessment and optimization of cell engraftment after transplantation into the heart,” Circulation Research, vol. 106, no. 3, pp. 479–494, 2010. View at Publisher · View at Google Scholar · View at Scopus
  163. K. L. Christman and R. J. Lee, “Biomaterials for the treatment of myocardial infarction,” Journal of the American College of Cardiology, vol. 48, no. 5, pp. 907–913, 2006. View at Publisher · View at Google Scholar · View at Scopus
  164. C. E. Murry, L. J. Field, and P. Menasché, “Cell-based cardiac repair: reflections at the 10-year point,” Circulation, vol. 112, no. 20, pp. 3174–3183, 2005. View at Publisher · View at Google Scholar · View at Scopus
  165. J. Müller-Ehmsen, P. Whittaker, R. A. Kloner et al., “Survival and development of neonatal rat cardiomyocytes transplanted into adult myocardium,” Journal of Molecular and Cellular Cardiology, vol. 34, no. 2, pp. 107–116, 2002. View at Publisher · View at Google Scholar · View at Scopus
  166. L. Zeng, Q. Hu, X. Wang et al., “Bioenergetic and functional consequences of bone marrow-derived multipotent progenitor cell transplantation in hearts with postinfarction left ventricular remodeling,” Circulation, vol. 115, no. 14, pp. 1866–1875, 2007. View at Publisher · View at Google Scholar · View at Scopus
  167. C. Lang, S. Lehner, A. Todica et al., “In-vivo comparison of the acute retention of stem cell derivatives and fibroblasts after intramyocardial transplantation in the mouse model,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 41, no. 12, pp. 2325–2336, 2014. View at Publisher · View at Google Scholar · View at Scopus
  168. R. Rakian, T. J. Block, S. M. Johnson et al., “Native extracellular matrix preserves mesenchymal stem cell ‘stemness’ and differentiation potential under serum-free culture conditions,” Stem Cell Research & Therapy, vol. 6, no. 1, article 235, 2015. View at Publisher · View at Google Scholar · View at Scopus
  169. V. Schächinger, S. Erbs, A. Elsässer et al., “Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial,” European Heart Journal, vol. 27, no. 23, pp. 2775–2783, 2006. View at Publisher · View at Google Scholar · View at Scopus
  170. A. Rosenzweig, “Cardiac cell therapy—mixed results from mixed cells,” The New England Journal of Medicine, vol. 355, no. 12, pp. 1274–1277, 2006. View at Publisher · View at Google Scholar · View at Scopus
  171. T. Umemura and Y. Higashi, “Endothelial progenitor cells: therapeutic target for cardiovascular diseases,” Journal of Pharmacological Sciences, vol. 108, no. 1, pp. 1–6, 2008. View at Publisher · View at Google Scholar · View at Scopus
  172. C. Beauséjour, “Bone marrow-derived cells: the influence of aging and cellular senescence,” Handbook of Experimental Pharmacology, vol. 180, pp. 67–88, 2007. View at Publisher · View at Google Scholar · View at Scopus
  173. O. M. Tepper, R. D. Galiano, J. M. Capla et al., “Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures,” Circulation, vol. 106, no. 22, pp. 2781–2786, 2002. View at Publisher · View at Google Scholar · View at Scopus
  174. C. J. M. Loomans, E. J. P. De Koning, F. J. T. Staal et al., “Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes,” Diabetes, vol. 53, no. 1, pp. 195–199, 2004. View at Publisher · View at Google Scholar · View at Scopus
  175. G. Lamirault, S. Susen, V. Forest et al., “Difference in mobilization of progenitor cells after myocardial infarction in smoking versus non-smoking patients: insights from the BONAMI trial,” Stem Cell Research and Therapy, vol. 4, no. 6, article no. 152, 2013. View at Publisher · View at Google Scholar · View at Scopus
  176. B.-E. Strauer and G. Steinhoff, “10 Years of intracoronary and intramyocardial bone marrow stem cell therapy of the heart: from the methodological origin to clinical practice,” Journal of the American College of Cardiology, vol. 58, no. 11, pp. 1095–1104, 2011. View at Publisher · View at Google Scholar · View at Scopus
  177. M. Gnecchi, Z. Zhang, A. Ni, and V. J. Dzau, “Paracrine mechanisms in adult stem cell signaling and therapy,” Circulation Research, vol. 103, no. 11, pp. 1204–1219, 2008. View at Publisher · View at Google Scholar · View at Scopus
  178. C. E. Murry, M. H. Soonpaa, H. Reinecke et al., “Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts,” Nature, vol. 428, no. 6983, pp. 664–668, 2004. View at Publisher · View at Google Scholar · View at Scopus
  179. M. Gnecchi, H. He, O. D. Liang et al., “Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells,” Nature Medicine, vol. 11, no. 4, pp. 367–368, 2005. View at Publisher · View at Google Scholar · View at Scopus
  180. M.-M. Zaruba, M. Soonpaa, S. Reuter, and L. J. Field, “Cardiomyogenic potential of C-Kit+–expressing cells derived from neonatal and adult mouse hearts,” Circulation, vol. 121, pp. 1992–2000, 2010. View at Publisher · View at Google Scholar
  181. D. C. Andersen, P. Andersen, M. Schneider, H. B. Jensen, and S. P. Sheikh, “Murine ‘cardiospheres’ are not a source of stem cells with cardiomyogenic potential,” STEM CELLS, vol. 27, no. 7, pp. 1571–1581, 2009. View at Publisher · View at Google Scholar · View at Scopus
  182. M. A. Laflamme and C. E. Murry, “Heart regeneration,” Nature, vol. 473, no. 7347, pp. 326–335, 2011. View at Publisher · View at Google Scholar · View at Scopus
  183. R. Jackson, E. L. Tilokee, N. Latham et al., “paracrine engineering of human cardiac stem cells with insulin‐like growth factor 1 enhances myocardial repair,” Journal of the American Heart Association, vol. 4, no. 9, Article ID e002104, 2015. View at Publisher · View at Google Scholar
  184. S. Minatoguchi, G. Takemura, X.-H. Chen et al., “Acceleration of the healing process and myocardial regeneration may be important as a mechanism of improvement of cardiac function and remodeling by postinfarction granulocyte colony-stimulating factor treatment,” Circulation, vol. 109, no. 21, pp. 2572–2580, 2004. View at Publisher · View at Google Scholar · View at Scopus
  185. S. Hamshere, S. Arnous, T. Choudhury et al., “Randomized trial of combination cytokine and adult autologous bone marrow progenitor cell administration in patients with non-ischaemic dilated cardiomyopathy: the REGENERATEDCM clinical trial,” European Heart Journal, vol. 36, no. 44, pp. 3061–3069, 2015. View at Publisher · View at Google Scholar · View at Scopus
  186. A. J. Boyle, R. Whitbourn, S. Schlicht et al., “Intra-coronary high-dose CD34+ stem cells in patients with chronic ischemic heart disease: a 12-month follow-up,” International Journal of Cardiology, vol. 109, no. 1, pp. 21–27, 2006. View at Publisher · View at Google Scholar · View at Scopus
  187. A. T. Askari, S. Unzek, Z. B. Popovic et al., “Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy,” The Lancet, vol. 362, no. 9385, pp. 697–703, 2003. View at Publisher · View at Google Scholar · View at Scopus
  188. G. Tan, W. Shim, Y. Gu et al., “Differential effect of myocardial matrix and integrins on cardiac differentiation of human mesenchymal stem cells,” Differentiation, vol. 79, no. 4-5, pp. 260–271, 2010. View at Publisher · View at Google Scholar · View at Scopus
  189. A. Behfar, S. Yamada, R. Crespo-Diaz et al., “Guided cardiopoiesis enhances therapeutic benefit of bone marrow human mesenchymal stem cells in chronic myocardial infarction,” Journal of the American College of Cardiology, vol. 56, no. 9, pp. 721–734, 2010. View at Publisher · View at Google Scholar · View at Scopus